Ibex Investors’s Mesa Laboratories MLAB Stock Holding History

Ibex Investors’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,962	Closed	-$414K	–	239
2018 Q2	$414K	Buy	+1,962	New	+$343K	0.23%	48

Other funds holding MLAB

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Ibex Investors's MLAB Position: Q3 2018 in Review

Ibex Investors sold out of Mesa Laboratories (MLAB) in Q3 2018, closing a stake of 1,962 shares — an estimated $414K sold.

Ibex Investors first reported a position in MLAB in Q2 2018 and held it in 1 quarter. The position peaked at $414K in Q2 2018. 107 funds tracked by Wall St. Rank hold MLAB as of Q3 2018.

Ibex Investors reported no remaining Mesa Laboratories position as of Q3 2018 after selling out during the quarter.
Ibex Investors sold 1,962 Mesa Laboratories shares in Q3 2018, an estimated $414K.
Ibex Investors first reported a position in Mesa Laboratories in Q2 2018 and held it in 1 quarter.
Ibex Investors's Mesa Laboratories position peaked at $414K in Q2 2018.
107 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2018.

Based on Ibex Investors's 13F filing for Q3 2018, filed 13 Nov 2018.